Exendin-4 (exenatide, Ex-4), an analog of glucagon like peptide-1 (GLP-1) [3], improves the function of β-cells and reduces fasting glucose levels, making it one of the most promising treatment methods for patients with T2DM [4]. This evidence concerns the gene GCG and type 2 diabetes mellitus.